Insider Buying: BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Buys 8,012 Shares of Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. purchased 8,012 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The shares were purchased at an average cost of 15.84 per share, for a total transaction of 126,910.08. Following the completion of the transaction, the insider now owns 20,661,390 shares in the company, valued at approximately 327,276,417.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Friday, September 27th, Saba Capital Management, L.P. bought 1,633 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.89 per share, with a total value of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. bought 300 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.73 per share, for a total transaction of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. purchased 2,006 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.98 per share, with a total value of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. acquired 15,455 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 16.14 per share, for a total transaction of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. bought 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.93 per share, with a total value of 432,467.64.

BlackRock Health Sciences Term Trust Trading Down 0.5 %

Shares of BlackRock Health Sciences Term Trust stock opened at 15.81 on Thursday. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.59. The business’s 50 day simple moving average is 15.85 and its 200-day simple moving average is 15.53.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be given a dividend of $0.176 per share. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 annualized dividend and a dividend yield of 13.36%.

Institutional Trading of BlackRock Health Sciences Term Trust

Hedge funds have recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. grew its position in BlackRock Health Sciences Term Trust by 21.7% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock worth $96,000 after purchasing an additional 1,038 shares during the last quarter. Register Financial Advisors LLC boosted its position in shares of BlackRock Health Sciences Term Trust by 5,365.6% during the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock worth $105,000 after buying an additional 6,707 shares during the period. Shaker Financial Services LLC bought a new position in BlackRock Health Sciences Term Trust in the 2nd quarter worth approximately $184,000. Comerica Bank increased its position in BlackRock Health Sciences Term Trust by 31.1% in the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after acquiring an additional 3,671 shares during the period. Finally, Dakota Wealth Management raised its stake in BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after acquiring an additional 915 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.